Helix BioPharma Corp.

TSX:HBP.TO

Biotechnology

Healthcare
$0.86 -4.70%

-$0.07 today

Market cap
$65.69M
Beta
-0.29
P/E (TTM)
-32.6
EPS (TTM)
-$0.04
52W Low $0.84High $5.40

Volume 0.00M

Average 0.00M

Returns on capital

Helix BioPharma Corp. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-33.4%

avg 6264.2%

ROIC

-33.9%

avg 6432.1%

ROA

-27.7%

avg -377.0%

Analysis

ROA is currently the strongest return metric at -27.7% versus its period average of -377.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Markus Loeffler

Chief Medical OfficerCAD 318.92K———

Thomas Mehrling

Chief Executive Officer & DirectorCAD 318.92K———

Rohit Babbar

Chief Financial OfficerCAD 243.77K———

Veronika Kandziora

Chief Operating OfficerCAD 232.24K———

Davide Guggi

Chief Technology OfficerCAD 213.6K———

Jacek Antas

Corporate SecretaryCAD 100K———

Natalia L. Butterworth

Corporate SecretaryCAD 100K———

Helen Middleton

General Counsel————

Jessica Kourniaktis DPHIL

Director of Communications————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A —
RevenueN/AN/AN/A
N/A —
Net IncomeN/AN/AN/A
N/A —
EBITN/AN/AN/A
N/A —

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Helix BioPharma Corp. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about HBP.TO's management, answered from reported figures.

Who manages HBP.TO?

Helix BioPharma Corp. (HBP.TO) lists 9 active executives. The top listed executive is Markus Loeffler, Chief Medical Officer.